The Use of Monoamine Oxidase Inhibitors in the Treatment of Elderly, Depressed Patients
- 1 August 1984
- journal article
- case report
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 32 (8) , 571-575
- https://doi.org/10.1111/j.1532-5415.1984.tb06134.x
Abstract
Depression is an extremely common illness in the elderly, and Is, at times, refractory to the usual therapies. The elderly are also particularly prone to develop toxic side effects from standard antidepressive agents. Monoamine oxidase inhibitors are rarely used in this population, although much evidence and clinical experience would indicate that they can be extremely effective and non-toxic. This paper outlines the indications and precautions for use and side effects of monoamine oxidase inhibitors in the treatment of depression in elderly patients.Keywords
This publication has 13 references indexed in Scilit:
- Toxicity Secondary to Meperidine in Patients on Monoamine Oxidase InhibitorsJournal of Clinical Psychopharmacology, 1981
- Monoamine Oxidase Inhibitors: Prescription and Patient ManagementThe International Journal of Psychiatry in Medicine, 1981
- Use of MAO inhibitors in elderly patientsAmerican Journal of Psychiatry, 1979
- Clinical Pharmacology of PhenelzineArchives of General Psychiatry, 1978
- Neurotransmitter enzyme abnormalities in senile dementiaJournal of the Neurological Sciences, 1977
- NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLEThe Lancet, 1977
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIAThe Lancet, 1977
- Mortality in Depressed Patients Treated With Electroconvulsive Therapy and AntidepressantsArchives of General Psychiatry, 1976
- Toxic Effects of Iproniazid in a Patient with AnginaBMJ, 1958
- FATAL TOXIC ENCEPHALITIS OCCURRING DURING IPRONIAZID THERAPY IN PULMONARY TUBERCULOSISAnnals of Internal Medicine, 1955